CA Stock MarketDetailed Quotes

AGN Algernon Pharmaceuticals Inc

Watchlist
  • 0.075
  • +0.005+7.14%
15min DelayMarket Closed Dec 13 15:59 ET
2.05MMarket Cap-2.21P/E (TTM)

About Algernon Pharmaceuticals Inc Company

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.

Company Profile

SymbolAGN
Company NameAlgernon Pharmaceuticals Inc
Founded2015
MarketCNQ
Employees4
Fiscal Year Ends08-31
Address601 West Broadway Suite 400
CityVancouver
CountryCAN
Zip CodeV5Z 4C2
Phone+1 604 398-4175

Company Executives

  • Name
  • Position
  • Salary
  • Christopher J. Moreau
  • Chief Executive Officer and Director
  • --
  • James Kinley
  • Chief Financial Officer and Director
  • --
  • Dr. Christopher Bryan
  • Vice President, Research and Operations
  • --
  • Harry J. F. Bloomfield
  • Chairman of the Board
  • --
  • Dr. Ahmad Khalil
  • Medical Director
  • --
  • Howard Gutman
  • Director
  • --
  • Dr. Raj Attariwala
  • Director
  • --
  • Dr. Mark Williams
  • Director
  • --
Heat List
CA
Overall
Symbol
Price
% Chg

No Data